Metropolitan Life Insurance CO Ovid Therapeutics Inc. Transaction History

Metropolitan Life Insurance CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$2.72 - $4.04 $6,283 - $9,332	-2,310 Reduced 70.28%	977 $2,000
Q2 2023 Aug 10, 2023	BUY	$2.53 - $3.89 $8,316 - $12,786	3,287 New	3,287 $10,000
Q4 2020 Feb 16, 2021	SELL	$2.28 - $6.84 $16,525 - $49,576	-7,248 Closed	0 $0
Q3 2020 Jun 26, 2023	BUY	$5.39 - $8.24 $39,066 - $59,723	7,248 New	7,248 $41,000
Q3 2020 Mar 30, 2023	SELL	$5.39 - $8.24 $38,872 - $59,426	-7,212 Reduced 49.88%	7,248 $41,000
Q3 2020 Nov 13, 2020	SELL	$5.39 - $8.24 $38,872 - $59,426	-7,212 Reduced 49.88%	7,248 $42,000
Q2 2020 Jun 26, 2023	BUY	$2.67 - $7.91 $38,608 - $114,378	14,460 New	14,460 $106,000
Q2 2020 Mar 30, 2023	BUY	$2.67 - $7.91 $38,608 - $114,378	14,460 New	14,460 $106,000
Q2 2020 Aug 14, 2020	BUY	$2.67 - $7.91 $38,608 - $114,378	14,460 New	14,460 $107,000

39M

37.4K

500

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $73.2M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.